INTERVIEW: Admedus cardiovascular scaffold could cut repeat surgeries
This article was originally published in Clinica
Executive Summary
Xenografts of animal tissue (usually from cows or pigs) are commonly used for patients with structural heart problems, but have several drawbacks. The main issue is that the tissue calcifies so need to be replaced regularly. In the case of children with congenital heart disease (CHD), this means several repeat operations at a young age, which is stressful and can cause other health problems itself.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.